Table 2.

Summary of Guidelines on Initiation, Discontinuation, and Frequency of Surveillance Mammography

Society and Year	Initiation	Discontinuation	Frequency
American Cancer Society (ACS) and American Society of Clinical Oncology (ASCO), 2015 [15]	Not specified	Not specified	Annual
National Comprehensive Cancer Network (NCCN), 2021 [16]	6–12 months after completion of radiation therapy	Not specified	Annual
American College of Radiology (ACR), 2018 [17], 2019 [18],	Not specified	Not specified	Annual
American Society of Breast Surgeons, 2019 [19]	Not specified	Not specified	Annual
Canadian Cancer Society [20]	6 months after completion of treatment	Not specified	Annual
Canadian Association of Radiologists, 2016 [21]	Not specified	Not specified	Not specified
National Institute for Health and Care Excellence (United Kingdom), 2018 [22]	Not specified	Surveillance until age 50 or for 5 years, then return to population screening (non-high-risk women)	Annual for 5 years or until age 50, then return to every 3 years
European Society for Medical Oncology (ESMO), 2019 [23]	Not specified	Not specified	Annual
Oncology societies of Korea (KSMO), China (CSCO), India (ISMPO), Japan (JSMO), Malaysia (MOS), Singapore (SSO), and Taiwan (TOS), 2020 [24]	Not specified	Not specified	Annual
Cancer Australia, 2020 [26]	12 months after diagnosis	Not specified	Annual
International Society of Geriatric Oncology (SIOG), 2021 [29]	Not specified	-When life expectancy is < 5 years, including those with a history of high-risk cancers -Consider when life expectancy is 5 to 10 years	Annual or biennial (based on cancer risk and age)

CSCO = Chinese Society of Clinical Oncology, ISMPO =1 ndian Society of Medical and Pediatric Oncology, JSMO = Japanese Society of Medical Oncology, KSMO = Korean Society of Medical Oncology, MOS = Malaysian Oncological Society, SSO = Singapore Society of Oncology, TOS = Taiwan Oncology Society